Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

26 to 50 of 554 results

Russian government to change mechanism for setting prices for essential drugs

Russian government to change mechanism for setting prices for essential drugs

10-12-2013

The Russian government is considering changing the mechanism of setting prices for essential drugs in…

Eastern EuropeGenericsPharmaceuticalPricingRussia

Low level of “potentially problematic” patent settlements in EU pharma sector

Low level of “potentially problematic” patent settlements in EU pharma sector

09-12-2013

The European Commission's report on patent settlement agreements, also referred to as “pay-for-delay”…

EuropeFinancialGenericsPatentsPharmaceutical

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Increase in chronic and lifestyle-associated diseases to Brazil market sales

Increase in chronic and lifestyle-associated diseases to Brazil market sales

11-10-2013

Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma…

GenericsPharmaceuticalSouth America

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands

04-10-2013

The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…

EuropeGenericsLegalNeurologicalPatentsPharmaceutical

Modest growth forecast for Greek pharma market, despite unstable economy

04-10-2013

The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek…

EuropeGenericsHealthcareMarkets & MarketingPharmaceuticalPricing

Promising outcome of EU platform on access to medicines in Africa

17-09-2013

The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Increase of Japan's medical expenditure slowed to 1.7% in 2012

17-09-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…

Asia-PacificFinancialGenericsHealthcarePharmaceutical

Canada's Health Minister sets out plan to help reduce impact of drug shortages

16-09-2013

A national protocol for the public notification of drug shortages and a toolkit that identifies steps…

GenericsHealthcareNorth AmericaPharmaceuticalRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia

13-09-2013

USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Russian billionaire to acquire control of Veropharm

03-09-2013

Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Lundbeck files appeal over EC pay-for-delay fine

02-09-2013

Denmark-based CNS specialist drugmaker Lundbeck (LUND: CO) has filed its appeal against the European…

citalopramEuropeFinancialGenericsLegalLundbeckPharmaceutical

Teva to drop development of Nuvigil in bipolar 1 disorder

31-08-2013

Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results

28-08-2013

Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

26 to 50 of 554 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top